We are analyzing https://link.springer.com/article/10.1186/s12935-018-0559-2.

Title:
Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer | Cancer Cell International
Description:
Background Ovarian cancer is the most lethal gynaecological malignancy. Chemotherapy is the main stay of treatment for metastatic disease, with modest response rates but significant side effects. Therefore, there is a need for alternative therapies that can control the disease while offering good quality of life. Ovarian cancer cells express both estrogen receptor subtypes (ERα and ERβ). There is growing evidence that ERβ is anti-oncogenic. Genistein and daidzein are phytoestrogens found in soybeans and they display higher affinity to bind ERβ. ERB-041 is a potent selective ERβ agonist. In this study, we aimed to investigate the effects of genistein, daidzein and ERB-041 on ovarian cancer. Methods Ovarian cancer cell lines were treated with genistein, daidzein and ERB-041 in pharmacological doses. Cell migration, invasion, proliferation, cell cycle arrest, apoptosis and sphere formation were assessed by Transwell migration and invasion assays, XTT assay, focus formation, flow cytometry and sphere formation assay, respectively. Immunoblotting analysis was performed to determine the downstream signaling pathways. Results We found that genistein, daidzein and ERB-041 significantly inhibited ovarian cancer cell migration, invasion, proliferation, as well as induced cell cycle arrest and apoptosis. Significantly inhibitory effect on the size and number of sphere formed in genistein, daidzein and ERB-041 treated cells was also demonstrated. Moreover, genistein, daidzein and ERB-041 treatment reduced p-FAK, p-PI3K, p-AKT, p-GSK3β, p21 or cyclin D1 expression in ovarian cancer cells. Conclusion Genistein, daidzein and ERB-041 decreased ovarian cancer cell migration, invasion, proliferation and sphere formation, and induced cell cycle arrest and apoptosis with altered FAK and PI3K/AKT/GSK signaling and p21/cyclin D1 expression, suggesting their roles on ovarian cancer cell metastasis, tumorigenesis and stem-like properties and their potential as alternative therapies for ovarian cancer patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cancer, cell, cells, genistein, ovarian, daidzein, erb, pubmed, article, invasion, migration, google, scholar, cas, cycle, erβ, skov, fig, proliferation, treated, signaling, expression, estrogen, formation, sphere, arrest, apoptosis, found, effect, acp, receptor, treatment, control, erα, effects, ovcar, pathway, fak, reduced, cancers, central, assay, induced, breast, panel, kinase, data, study, stemlike, clinical,

Topics {✒️}

4′-di-n-octyl genistein annexin-v-fluos staining kit annexin-v-fluos staining presented serum-free dmem/f12 supplemented pi3k/akt/mtor signaling pathway modulate pi3k85/akt/gsk3β signaling uvb-induced skin tumors estrogen receptor-β agonist estrogen receptor-dependent pathway article download pdf nf-kappab/ap-1-dependent stem-condition culture systems cyclin-dependent kinases cdk2 targeting estrogen receptor-β cyclin-dependent kinase inhibitor tgf-beta signaling pathway erb-041 decreased p-pi3k85 metformin induces degradation control cells dose-dependently stem cell-condition medium cytochrome c-mediated apoptosis genistein augmented csc regulation pi3k/akt/gsk signaling genistein-induced neuronal apoptosis inhibits skin photocarcinogenesis green fluorescent-stained cells selective er modulators display anti-neoplastic activity understanding er-beta signaling affect cell cycle p21/cyclin d1 expression estrogen receptor beta estrogen receptor pathway cell cycle arrest human hepatocellular carcinoma reduced cell proliferation epithelial ovarian cancer ms designed research altere e-cadherin expression cell cycle regulators ovarian cell proliferation estrogen receptor subtypes privacy choices/manage cookies cancer cell migration epithelial–mesenchymal transition natl cancer inst inhibit cell proliferation cancer cell proliferation focal adhesion kinase regulate cell cycle

Questions {❓}

Hormone response in ovarian cancer: time to reconsider as a clinical target?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer
         description:Ovarian cancer is the most lethal gynaecological malignancy. Chemotherapy is the main stay of treatment for metastatic disease, with modest response rates but significant side effects. Therefore, there is a need for alternative therapies that can control the disease while offering good quality of life. Ovarian cancer cells express both estrogen receptor subtypes (ERα and ERβ). There is growing evidence that ERβ is anti-oncogenic. Genistein and daidzein are phytoestrogens found in soybeans and they display higher affinity to bind ERβ. ERB-041 is a potent selective ERβ agonist. In this study, we aimed to investigate the effects of genistein, daidzein and ERB-041 on ovarian cancer. Ovarian cancer cell lines were treated with genistein, daidzein and ERB-041 in pharmacological doses. Cell migration, invasion, proliferation, cell cycle arrest, apoptosis and sphere formation were assessed by Transwell migration and invasion assays, XTT assay, focus formation, flow cytometry and sphere formation assay, respectively. Immunoblotting analysis was performed to determine the downstream signaling pathways. We found that genistein, daidzein and ERB-041 significantly inhibited ovarian cancer cell migration, invasion, proliferation, as well as induced cell cycle arrest and apoptosis. Significantly inhibitory effect on the size and number of sphere formed in genistein, daidzein and ERB-041 treated cells was also demonstrated. Moreover, genistein, daidzein and ERB-041 treatment reduced p-FAK, p-PI3K, p-AKT, p-GSK3β, p21 or cyclin D1 expression in ovarian cancer cells. Genistein, daidzein and ERB-041 decreased ovarian cancer cell migration, invasion, proliferation and sphere formation, and induced cell cycle arrest and apoptosis with altered FAK and PI3K/AKT/GSK signaling and p21/cyclin D1 expression, suggesting their roles on ovarian cancer cell metastasis, tumorigenesis and stem-like properties and their potential as alternative therapies for ovarian cancer patients.
         datePublished:2018-05-01T00:00:00Z
         dateModified:2018-05-01T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12935-018-0559-2
         keywords:
            Genistein
            Daidzein
            ERB-041
            Ovarian cancer
            Cancer Research
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig8_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig9_HTML.gif
         isPartOf:
            name:Cancer Cell International
            issn:
               1475-2867
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Karen K. L. Chan
               affiliation:
                     name:University of Hong Kong
                     address:
                        name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Michelle K. Y. Siu
               affiliation:
                     name:University of Hong Kong
                     address:
                        name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu-xin Jiang
               affiliation:
                     name:University of Hong Kong
                     address:
                        name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jing-jing Wang
               affiliation:
                     name:University of Hong Kong
                     address:
                        name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas H. Y. Leung
               affiliation:
                     name:University of Hong Kong
                     address:
                        name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hextan Y. S. Ngan
               affiliation:
                     name:University of Hong Kong
                     address:
                        name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer
      description:Ovarian cancer is the most lethal gynaecological malignancy. Chemotherapy is the main stay of treatment for metastatic disease, with modest response rates but significant side effects. Therefore, there is a need for alternative therapies that can control the disease while offering good quality of life. Ovarian cancer cells express both estrogen receptor subtypes (ERα and ERβ). There is growing evidence that ERβ is anti-oncogenic. Genistein and daidzein are phytoestrogens found in soybeans and they display higher affinity to bind ERβ. ERB-041 is a potent selective ERβ agonist. In this study, we aimed to investigate the effects of genistein, daidzein and ERB-041 on ovarian cancer. Ovarian cancer cell lines were treated with genistein, daidzein and ERB-041 in pharmacological doses. Cell migration, invasion, proliferation, cell cycle arrest, apoptosis and sphere formation were assessed by Transwell migration and invasion assays, XTT assay, focus formation, flow cytometry and sphere formation assay, respectively. Immunoblotting analysis was performed to determine the downstream signaling pathways. We found that genistein, daidzein and ERB-041 significantly inhibited ovarian cancer cell migration, invasion, proliferation, as well as induced cell cycle arrest and apoptosis. Significantly inhibitory effect on the size and number of sphere formed in genistein, daidzein and ERB-041 treated cells was also demonstrated. Moreover, genistein, daidzein and ERB-041 treatment reduced p-FAK, p-PI3K, p-AKT, p-GSK3β, p21 or cyclin D1 expression in ovarian cancer cells. Genistein, daidzein and ERB-041 decreased ovarian cancer cell migration, invasion, proliferation and sphere formation, and induced cell cycle arrest and apoptosis with altered FAK and PI3K/AKT/GSK signaling and p21/cyclin D1 expression, suggesting their roles on ovarian cancer cell metastasis, tumorigenesis and stem-like properties and their potential as alternative therapies for ovarian cancer patients.
      datePublished:2018-05-01T00:00:00Z
      dateModified:2018-05-01T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12935-018-0559-2
      keywords:
         Genistein
         Daidzein
         ERB-041
         Ovarian cancer
         Cancer Research
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig8_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-018-0559-2/MediaObjects/12935_2018_559_Fig9_HTML.gif
      isPartOf:
         name:Cancer Cell International
         issn:
            1475-2867
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Karen K. L. Chan
            affiliation:
                  name:University of Hong Kong
                  address:
                     name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Michelle K. Y. Siu
            affiliation:
                  name:University of Hong Kong
                  address:
                     name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu-xin Jiang
            affiliation:
                  name:University of Hong Kong
                  address:
                     name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jing-jing Wang
            affiliation:
                  name:University of Hong Kong
                  address:
                     name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas H. Y. Leung
            affiliation:
                  name:University of Hong Kong
                  address:
                     name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hextan Y. S. Ngan
            affiliation:
                  name:University of Hong Kong
                  address:
                     name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Cell International
      issn:
         1475-2867
      volumeNumber:18
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Hong Kong
      address:
         name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:University of Hong Kong
      address:
         name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:University of Hong Kong
      address:
         name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:University of Hong Kong
      address:
         name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:University of Hong Kong
      address:
         name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
         type:PostalAddress
      name:University of Hong Kong
      address:
         name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Karen K. L. Chan
      affiliation:
            name:University of Hong Kong
            address:
               name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Michelle K. Y. Siu
      affiliation:
            name:University of Hong Kong
            address:
               name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Yu-xin Jiang
      affiliation:
            name:University of Hong Kong
            address:
               name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Jing-jing Wang
      affiliation:
            name:University of Hong Kong
            address:
               name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Thomas H. Y. Leung
      affiliation:
            name:University of Hong Kong
            address:
               name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Hextan Y. S. Ngan
      affiliation:
            name:University of Hong Kong
            address:
               name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
      name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
      name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
      name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
      name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
      name:Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, China

External Links {🔗}(189)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.78s.

LINK . SPRINGER . COM {}